vs
史密斯威森(SWBI)与Tilray Brands, Inc.(TLRY)财务数据对比。点击上方公司名可切换其他公司
Tilray Brands, Inc.的季度营收约是史密斯威森的1.7倍($217.5M vs $124.7M),史密斯威森净利率更高(1.5% vs -20.7%,领先22.2%),Tilray Brands, Inc.同比增速更快(3.1% vs -3.9%),过去两年Tilray Brands, Inc.的营收复合增速更高(7.5% vs -4.8%)
史密斯韦森品牌公司是总部位于美国田纳西州玛丽维尔的美国枪械制造商,是美国历史悠久的知名枪械生产企业,在民用和执法枪械领域拥有较高的市场知名度。
Tilray Brands, Inc.是一家美国企业,主营医药、大麻生活方式产品以及包装消费品业务,公司注册于美国,总部坐落于纽约。该公司在加拿大、澳大利亚、新西兰、拉美地区均开展业务,同时在德国和葡萄牙拥有大麻种植基地。
SWBI vs TLRY — 直观对比
营收规模更大
TLRY
是对方的1.7倍
$124.7M
营收增速更快
TLRY
高出7.0%
-3.9%
净利率更高
SWBI
高出22.2%
-20.7%
两年增速更快
TLRY
近两年复合增速
-4.8%
损益表 — Q2 FY2026 vs Q2 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $124.7M | $217.5M |
| 净利润 | $1.9M | $-44.9M |
| 毛利率 | 24.3% | 26.4% |
| 营业利润率 | 3.3% | -10.2% |
| 净利率 | 1.5% | -20.7% |
| 营收同比 | -3.9% | 3.1% |
| 净利润同比 | -53.6% | 47.4% |
| 每股收益(稀释后) | $0.04 | $-0.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
SWBI
TLRY
| Q4 25 | $124.7M | $217.5M | ||
| Q3 25 | $85.1M | $209.5M | ||
| Q2 25 | $140.8M | $224.5M | ||
| Q1 25 | $115.9M | $185.8M | ||
| Q4 24 | $129.7M | $210.9M | ||
| Q3 24 | $88.3M | $200.0M | ||
| Q2 24 | $159.1M | $229.9M | ||
| Q1 24 | $137.5M | $188.3M |
净利润
SWBI
TLRY
| Q4 25 | $1.9M | $-44.9M | ||
| Q3 25 | $-3.4M | $-322.0K | ||
| Q2 25 | $8.6M | $-1.3B | ||
| Q1 25 | $2.1M | $-789.4M | ||
| Q4 24 | $4.5M | $-85.3M | ||
| Q3 24 | $-1.9M | $-39.2M | ||
| Q2 24 | $27.9M | $-31.7M | ||
| Q1 24 | $7.9M | $-92.7M |
毛利率
SWBI
TLRY
| Q4 25 | 24.3% | 26.4% | ||
| Q3 25 | 25.9% | 27.4% | ||
| Q2 25 | 28.8% | 30.1% | ||
| Q1 25 | 24.1% | 28.0% | ||
| Q4 24 | 26.6% | 29.0% | ||
| Q3 24 | 27.4% | 29.8% | ||
| Q2 24 | 35.5% | 35.8% | ||
| Q1 24 | 28.7% | 26.2% |
营业利润率
SWBI
TLRY
| Q4 25 | 3.3% | -10.2% | ||
| Q3 25 | -3.5% | 1.0% | ||
| Q2 25 | 9.3% | -643.1% | ||
| Q1 25 | 4.1% | -409.0% | ||
| Q4 24 | 5.8% | -20.0% | ||
| Q3 24 | -1.7% | -18.3% | ||
| Q2 24 | 17.4% | -7.2% | ||
| Q1 24 | 8.2% | -43.6% |
净利率
SWBI
TLRY
| Q4 25 | 1.5% | -20.7% | ||
| Q3 25 | -4.0% | -0.2% | ||
| Q2 25 | 6.1% | -566.9% | ||
| Q1 25 | 1.8% | -424.9% | ||
| Q4 24 | 3.5% | -40.5% | ||
| Q3 24 | -2.1% | -19.6% | ||
| Q2 24 | 17.5% | -13.8% | ||
| Q1 24 | 5.7% | -49.2% |
每股收益(稀释后)
SWBI
TLRY
| Q4 25 | $0.04 | $-0.41 | ||
| Q3 25 | $-0.08 | $0.00 | ||
| Q2 25 | $0.19 | $7.26 | ||
| Q1 25 | $0.05 | $-8.69 | ||
| Q4 24 | $0.10 | $-0.99 | ||
| Q3 24 | $-0.04 | $-0.04 | ||
| Q2 24 | $0.60 | $-0.04 | ||
| Q1 24 | $0.17 | $-0.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $22.4M | $291.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $363.2M | $1.6B |
| 总资产 | $548.6M | $2.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
SWBI
TLRY
| Q4 25 | $22.4M | $291.6M | ||
| Q3 25 | $18.0M | $264.8M | ||
| Q2 25 | $25.2M | $256.4M | ||
| Q1 25 | $26.7M | — | ||
| Q4 24 | $39.1M | $252.2M | ||
| Q3 24 | $35.5M | $280.1M | ||
| Q2 24 | $60.8M | $260.5M | ||
| Q1 24 | $47.4M | $225.9M |
股东权益
SWBI
TLRY
| Q4 25 | $363.2M | $1.6B | ||
| Q3 25 | $364.4M | $1.5B | ||
| Q2 25 | $372.5M | $1.5B | ||
| Q1 25 | $366.9M | $2.7B | ||
| Q4 24 | $371.5M | $3.5B | ||
| Q3 24 | $380.0M | $3.5B | ||
| Q2 24 | $399.9M | $3.4B | ||
| Q1 24 | $376.4M | $3.4B |
总资产
SWBI
TLRY
| Q4 25 | $548.6M | $2.1B | ||
| Q3 25 | $554.6M | $2.1B | ||
| Q2 25 | $559.6M | $2.1B | ||
| Q1 25 | $578.9M | — | ||
| Q4 24 | $587.4M | $4.2B | ||
| Q3 24 | $571.3M | $4.3B | ||
| Q2 24 | $577.4M | $4.2B | ||
| Q1 24 | $570.6M | $4.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $27.3M | $-8.5M |
| 自由现金流经营现金流 - 资本支出 | $16.3M | — |
| 自由现金流率自由现金流/营收 | 13.1% | — |
| 资本支出强度资本支出/营收 | 8.8% | — |
| 现金转化率经营现金流/净利润 | 14.22× | — |
| 过去12个月自由现金流最近4个季度 | $21.3M | — |
8季度趋势,按日历期对齐
经营现金流
SWBI
TLRY
| Q4 25 | $27.3M | $-8.5M | ||
| Q3 25 | $-8.1M | $-1.3M | ||
| Q2 25 | $40.8M | $-12.8M | ||
| Q1 25 | $-9.8M | $-5.8M | ||
| Q4 24 | $-7.4M | $-40.7M | ||
| Q3 24 | $-30.8M | $-35.3M | ||
| Q2 24 | $43.7M | $30.7M | ||
| Q1 24 | $25.2M | $-15.4M |
自由现金流
SWBI
TLRY
| Q4 25 | $16.3M | — | ||
| Q3 25 | $-12.4M | — | ||
| Q2 25 | $33.5M | $-19.1M | ||
| Q1 25 | $-16.1M | $-20.2M | ||
| Q4 24 | $-10.7M | $-46.2M | ||
| Q3 24 | $-35.5M | $-42.0M | ||
| Q2 24 | $38.2M | $21.0M | ||
| Q1 24 | $7.0M | $-24.9M |
自由现金流率
SWBI
TLRY
| Q4 25 | 13.1% | — | ||
| Q3 25 | -14.6% | — | ||
| Q2 25 | 23.8% | -8.5% | ||
| Q1 25 | -13.9% | -10.9% | ||
| Q4 24 | -8.3% | -21.9% | ||
| Q3 24 | -40.2% | -21.0% | ||
| Q2 24 | 24.0% | 9.1% | ||
| Q1 24 | 5.1% | -13.2% |
资本支出强度
SWBI
TLRY
| Q4 25 | 8.8% | — | ||
| Q3 25 | 5.0% | — | ||
| Q2 25 | 5.2% | 2.8% | ||
| Q1 25 | 5.4% | 7.8% | ||
| Q4 24 | 2.5% | 2.6% | ||
| Q3 24 | 5.3% | 3.4% | ||
| Q2 24 | 3.5% | 4.2% | ||
| Q1 24 | 13.2% | 5.1% |
现金转化率
SWBI
TLRY
| Q4 25 | 14.22× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.73× | — | ||
| Q1 25 | -4.68× | — | ||
| Q4 24 | -1.63× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.57× | — | ||
| Q1 24 | 3.20× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
SWBI
暂无分部数据
TLRY
| Adultuse Cannabis Products | $62.4M | 29% |
| Other | $59.2M | 27% |
| Beverage Alcohol Business | $53.6M | 25% |
| International Cannabis Products | $20.2M | 9% |
| Wellness Business | $14.6M | 7% |
| Medical Cannabis Products | $6.2M | 3% |
| Wholesale Cannabis Products | $1.3M | 1% |